Abstract
The primary function of a B cell (or lymphocyte) is to produce large quantity of secreted immunoglobulin (also known as antibody) to fight against bacteria, viruses and other foreign insults to the human body. Each B cell makes only one distinct immunoglobulin which recognizes a cognate antigen. It is estimated that B cells in the human body can produce as many as 1011 different antibodies. Thus, each B cell must undergo a series of differentiation, selection and maturation processes before it is endowed with the ability to produce a functional immunoglobulin to represent in the large and diverse antibody repertoire. While insufficient B cells and insufficient antibody production can thus lead to infections, uncontrolled growth of B cells can lead to leukemia and lymphoma. In this article, we will focus on transcription factors and signaling molecules that involve in normal B cell development and differentiation. These molecules, when mutated or not tightly regulated, will contribute the formation of B cell malignancies.
Original language | English (US) |
---|---|
Title of host publication | Hematologic Cancers |
Subtitle of host publication | From Molecular Pathobiology to Targeted Therapeutics |
Publisher | Springer Netherlands |
Pages | 1-20 |
Number of pages | 20 |
ISBN (Electronic) | 9789400750289 |
ISBN (Print) | 9789400750272 |
DOIs | |
State | Published - Jan 1 2012 |
ASJC Scopus subject areas
- Medicine(all)